Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.

Cell | Jul 7, 2000

http://www.ncbi.nlm.nih.gov/pubmed/10929712

To identify proteins that bind mammalian IAP homolog A (MIHA, also known as XIAP), we used coimmuno-precipitation and 2D immobilized pH gradient/SDS PAGE, followed by electrospray ionization tandem mass spectrometry. DIABLO (direct IAP binding protein with low pI) is a novel protein that can bind MIHA and can also interact with MIHB and MIHC and the baculoviral IAP, OpIAP. The N-terminally processed, IAP-interacting form of DIABLO is concentrated in membrane fractions in healthy cells but released into the MIHA-containing cytosolic fractions upon UV irradiation. As transfection of cells with DIABLO was able to counter the protection afforded by MIHA against UV irradiation, DIABLO may promote apoptosis by binding to IAPs and preventing them from inhibiting caspases.

Pubmed ID: 10929712 RIS Download

Mesh terms: Amino Acid Sequence | Animals | Apoptosis | Carrier Proteins | Cell Line, Transformed | Cloning, Molecular | Cysteine Proteinase Inhibitors | Gene Expression | Humans | Inhibitor of Apoptosis Proteins | Intracellular Signaling Peptides and Proteins | Mammals | Mice | Mitochondrial Proteins | Molecular Sequence Data | Nucleopolyhedrovirus | Proteins | Sequence Homology, Amino Acid | Subcellular Fractions | Viral Proteins | X-Linked Inhibitor of Apoptosis Protein

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.